<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">inovmed</journal-id><journal-title-group><journal-title xml:lang="ru">Инновационная медицина Кубани</journal-title><trans-title-group xml:lang="en"><trans-title>Innovative Medicine of Kuban</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2541-9897</issn><publisher><publisher-name>Scientific Research Institute – Ochapovsky Regional Clinical Hospital No. 1</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.35401/2500-0268-2019-14-2-67-75</article-id><article-id custom-type="elpub" pub-id-type="custom">inovmed-198</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>Возможности кровосбережения при родоразрешении пациенток с врастанием плаценты</article-title><trans-title-group xml:lang="en"><trans-title>Blood saving possibilities in delivering patients with placenta increta</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6793-2318</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Плахотина</surname><given-names>Е. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Plakhotina</surname><given-names>E. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Плахотина Елена Николаевна – доктор медицинских наук, заведующая отделением анестезиологии и реанимации</p><p>142700, Московская область, Видное, ул. Заводская, 17</p></bio><bio xml:lang="en"><p>Plakhotina Elena N. – Dr. of Sci. (Med.), Head of Anesthesiology and Resuscitation, Vidnovsky Perinatal Center</p><p>142700, Moscow region, Vidnoe, 17, Zavodskaya str.</p></bio><email xlink:type="simple">enp2004@inbox.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3804-7691</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Белоусова</surname><given-names>Т. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Belousova</surname><given-names>T. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Белоусова Тамара Николаевна – кандидат медицинских наук, главный врач</p><p>142700, Московская область, Видное, ул. Заводская, 17</p></bio><bio xml:lang="en"><p>Belousova Tamara N. – Cand. of Sci. (Med), Сhief doctor of  Vidnovsky Perinatal Center</p><p>142700, Moscow region, Vidnoe, 17, Zavodskaya str.</p></bio><email xlink:type="simple">beltamara1@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2460-1623</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Куликов</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kulikov</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Куликов Ильяс Александрович – кандидат медицинских наук, заведующий отделением патологии беременности</p><p>142700, Московская область, Видное, ул. Заводская, 17</p></bio><bio xml:lang="en"><p>Kulikov Ilyas A. – Cand. of Sci. (Med), Head of the department of pathology of pregnancy, Vidnovsky Perinatal Center</p><p>142700, Moscow region, Vidnoe, 17, Zavodskaya str.</p></bio><email xlink:type="simple">aesculap@inbox.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7051-0212</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Павлютина</surname><given-names>К. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Pavlyutina</surname><given-names>K. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Павлютина Карина Михайловна – врач – анестезиолог-реаниматолог отделения анестезиологии и реанимации</p><p>142700, Московская область, Видное, ул. Заводская, 17</p></bio><bio xml:lang="en"><p>Pavlyutina Karina M. – anesthesiologist-resuscitator of the Department of Anesthesiology and Resuscitation</p><p>142700, Moscow region, Vidnoe, 17, Zavodskaya str.</p></bio><email xlink:type="simple">pavlyutinak@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9864-7205</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Латышев</surname><given-names>Р. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Latyshev</surname><given-names>R. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Латышев Роман Вячеславович – врач – анестезиолог-реаниматолог отделения анестезиологии и реанимации</p><p>142700, Московская область, Видное, ул. Заводская, 17</p></bio><bio xml:lang="en"><p>Latyshev Roman V. – anesthesiologist-resuscitator of the Department of Anesthesiology and Resuscitation</p><p>142700, Moscow region, Vidnoe, 17, Zavodskaya str.</p></bio><email xlink:type="simple">roman_red-green@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБУЗ Московской области «Видновский перинатальный центр»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Vidnovsky Perinatal Center, Moscow region</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>30</day><month>06</month><year>2019</year></pub-date><volume>0</volume><issue>2</issue><fpage>67</fpage><lpage>75</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Плахотина Е.Н., Белоусова Т.Н., Куликов И.А., Павлютина К.М., Латышев Р.В., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Плахотина Е.Н., Белоусова Т.Н., Куликов И.А., Павлютина К.М., Латышев Р.В.</copyright-holder><copyright-holder xml:lang="en">Plakhotina E.N., Belousova T.N., Kulikov I.A., Pavlyutina K.M., Latyshev R.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.innovmedkub.ru/jour/article/view/198">https://www.innovmedkub.ru/jour/article/view/198</self-uri><abstract><p>По результатам систематических обзоров ВОЗ, материнская летальность, связанная с массивным кровотечением, практически достигла 30% и не имеет тенденции к снижению. Среди основных причин массивных акушерских кровотечений конкурируют гипотония матки и нарушения плацентации. Наиболее грозным нарушением плацентации является врастание плаценты в стенку матки. За последние 50 лет количество врастаний плаценты увеличилось в десять раз. Эта патология по всем признакам приняла характер эпидемии и является одной из основных причин перипартальной гистерэктомии и осложнений, связанных с донорскими гемотрансфузиями. Среди методов, используемых для хирургического гемостаза при данной патологии, выделяют рентгенваскулярные (временную баллонную окклюзию крупных сосудов, эмболизацию сосудов), перевязку подвздошных, маточных, яичниковых артерий, различные варианты дистального гемостаза, включающие использование маточных турникетов, внутриматочных и вагинальных баллонов, компрессионных швов и т. д. Однако данных, подтверждающих преимущество какого-либо из перечисленных методов, недостаточно. Риск развития массивного кровотечения сохраняется высоким при использовании любого из перечисленных методов. В статье проведен анализ существующих на современном  этапе методов кровосбережения, описана возможность применения этих методов в акушерстве, эффективность и безопасность их использования при массивной кровопотере, в том числе при оперативном лечении врастания плаценты.</p></abstract><trans-abstract xml:lang="en"><p>According to the results of systematic reviews of WHO, maternal mortality associated with massive bleeding almost reached 30% and has no tendency to decrease. Among the causes of massive obstetric hemorrhage, the most challenging ones are uterine hypotension and morbidity adherence placenta. Most severe complication for placentation is placenta increta in the uterine wall. Over the past 50 years, the number of cases with morbidity adherence placenta has increased tenfold. By all indications, this pathology has taken on the character of an epidemic and is one of the main causes for massive blood loss and blood transfusion, as well as peripartum hysterectomy. For surgical hemostasis in this pathology we apply X-ray vascular methods (temporary balloon occlusion of large vessels, vascular embolization), ligation of the iliac, uterine, ovarian arteries, various versions of distal hemostasis, including the use of uterine turnstiles, intrauterine and vaginal cylinders, compression sutures. However, data confirming the advantage of any specified methods are not enough. The risk of massive bleeding is high while using any of these methods. The article analyzes the blood saving methods existing at the present stage and possibility of these methods usage in obstetrics. Besides, we describe efficacy and safety of their use in massive blood loss, including the surgical treatment of morbidity adherence placenta.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>врастание плаценты</kwd><kwd>массивная кровопотеря</kwd><kwd>методы кровосбережения</kwd></kwd-group><kwd-group xml:lang="en"><kwd>placenta increta</kwd><kwd>massive blood loss</kwd><kwd>blood saving methods</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Global causes of maternal death: a WHO systematic analysis/ Lale Say, Doris Chou, Alison Gemmill et al.// Lancet Glob Health. 2014. Т.2, №6. P. 323-333. DOI: 10.1016/S2214-109X(14)70227-X</mixed-citation><mixed-citation xml:lang="en">Global   causes   of   maternal   death:   a   WHO systematic   analysis/   Lale   Say,   Doris   Chou,   Alison Gemmill et al.// Lancet Glob Health. 2014. Т.2, №6. P. 323-333. DOI: 10.1016/S2214-109X(14)70227-X</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Clinical Analysis of Postpartum Hemorrhage Requiring Massive Transfusions at a Tertiary Center./ Hu J, Yu ZP, Wang P et al.// Chin Med Journal. 2017. №130. P. 581-585. DOI: 10.4103/0366-6999.200545</mixed-citation><mixed-citation xml:lang="en">Clinical Analysis of Postpartum Hemorrhage Requiring Massive Transfusions at a Tertiary Center./ Hu J, Yu ZP, Wang P et al.// Chin Med Journal. 2017. №130. P. 581-585. DOI: 10.4103/0366-6999.200545</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Kerry L. How do we manage blood product support in the massively hemorrhaging obstetric patient?/ L.Kerry, O’Brien, Lynne Uhl//Transfusion. 2016;56(9):2165-71. DOI: 10.1111/trf.13753</mixed-citation><mixed-citation xml:lang="en">Kerry  L.  How  do  we  manage  blood  product support  in  the  massively  hemorrhaging  obstetric patient?/   L.Kerry,   O’Brien,   Lynne   Uhl//Transfusion. 2016;56(9):2165-71. DOI: 10.1111/trf.13753</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Center of excellence for placenta accrete/ R.M. Silver, K.A. Fox, J.R. Barton et al.//American Journal of Obstetrics &amp; Gynecology. 2015.-May; 212(5):561-568. DOI:10.1016/j.ajog.2014.11.018</mixed-citation><mixed-citation xml:lang="en">Center of excellence for placenta accrete/ R.M. Silver, K.A. Fox, J.R. Barton et al.//American Journal of Obstetrics  &amp; Gynecology.  2015.-May;  212(5):561-568. DOI:10.1016/j.ajog.2014.11.018</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">A Standardized Approach for Transfusion Medicine Support in Patients With Morbidly Adherent Placenta/ A.K. Panigrahi, A. Yeaton-Massey, S. Bakhtary et al.// Anesthesia and analgesia. 2017;125(2):603-608. DOI: 10.1213/ANE.0000000000002050</mixed-citation><mixed-citation xml:lang="en">A Standardized Approach for Transfusion Medicine Support  in Patients  With  Morbidly Adherent  Placenta/ A.K. Panigrahi, A. Yeaton-Massey,  S. Bakhtary  et al.// Anesthesia and analgesia. 2017;125(2):603-608. DOI: 10.1213/ANE.0000000000002050</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Silver R.M. Placenta accreta spectrum: accreta, increta, and percreta. / R.M. Silver, K.D. Barbour //Obstet Gynecol Clin North Am. 2015 Jun;42(2):381-402. DOI: 10.1016/j.ogc.2015.01.014.</mixed-citation><mixed-citation xml:lang="en">Silver R.M. Placenta accreta spectrum: accreta, increta, and percreta. / R.M. Silver, K.D. Barbour //Obstet Gynecol Clin North Am. 2015 Jun;42(2):381-402.  DOI: 10.1016/j.ogc.2015.01.014.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Within country inequalities in caesarean section rates: observational study of 72 low and middle income countries/ A.A. Boatin, A. Schlotheuber, A. P. Betran, // BMJ. 2018;360:55 DOI: https://doi.org/10.1136/bmj.k55</mixed-citation><mixed-citation xml:lang="en">Within  country  inequalities  in  caesarean  section rates: observational study of 72 low and middle income countries/ A.A. Boatin, A. Schlotheuber, A. P. Betran, // BMJ. 2018;360:55 DOI: https://doi.org/10.1136/bmj.k55</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Robson S. J. Thirty years of the World Health Organization’s target caesarean section rate: time to move on/ SJ Robson, C. M. de Costa //Med J Aust. 2017 Mar 6;206(4):181-185. DOI:10.5694/mja16.00832</mixed-citation><mixed-citation xml:lang="en">Robson S. J. Thirty years of the World Health Organization’s target caesarean section rate: time to move on/ SJ Robson, C. M. de Costa //Med J Aust. 2017 Mar 6;206(4):181-185. DOI:10.5694/mja16.00832</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Maternal morbidity associated with multiple repeat cesarean deliveries: National Institute of Child Health and Human Development maternal-fetal medicine units network/ R.M. Silver, M.B. Landon, D.J. Rouse at al. // Obstetrics &amp; Gynecology.- 2006;107:1226-32. DOI:10.1097/01.aog.0000219750.79480.84</mixed-citation><mixed-citation xml:lang="en">Maternal morbidity associated with multiple repeat cesarean  deliveries:  National  Institute  of  Child  Health and    Human    Development    maternal-fetal    medicine units  network/  R.M.  Silver,  M.B.  Landon,  D.J.  Rouse at al. // Obstetrics &amp; Gynecology.- 2006;107:1226-32. DOI:10.1097/01.aog.0000219750.79480.84</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Obstetric Intensive Care Manual/ M.R. Foley et al. - 3 edition. -Postpartum hemorrhage, 2010.-29 с.</mixed-citation><mixed-citation xml:lang="en">Obstetric Intensive Care Manual/ M.R. Foley et al. - 3 edition. -Postpartum hemorrhage, 2010.-29 с.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Screening for morbidly adherent placenta in early pregnancy/ J. Panaiotova, M. Tokunaka, K. Krajewska et al// Ultrasound in obstetrics &amp; gynecology. 2019;53:101-106 DOI: 10.1002/uog.20104</mixed-citation><mixed-citation xml:lang="en">Screening for morbidly adherent placenta in early pregnancy/ J. Panaiotova, M. Tokunaka, K. Krajewska et al// Ultrasound in obstetrics &amp; gynecology. 2019;53:101-106 DOI: 10.1002/uog.20104</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">The management and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive study/ K. Fitzpatrick, S. Sellers, P. Spark et al. // BJOG. 2013 Aug 7. DOI: 10.1111/1471-0528.12405</mixed-citation><mixed-citation xml:lang="en">The   management   and   outcomes   of   placenta accreta, increta, and percreta in the UK: a population-based descriptive study/ K. Fitzpatrick, S. Sellers, P. Spark et al. // BJOG. 2013 Aug 7. DOI: 10.1111/1471-0528.12405</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Efrain Riveros-Perez. Retrospective analysis of obstetric and anesthetic management of patients with placenta accreta spectrum disorders./ Riveros-Perez E, Wood C.// International Journal of Gynecology &amp; Obstetrics. 2018 Mar;140(3):370-374. DOI: 10.1002/ijgo.12366</mixed-citation><mixed-citation xml:lang="en">Efrain Riveros-Perez. Retrospective analysis of obstetric and anesthetic management of patients with placenta  accreta  spectrum  disorders./  Riveros-Perez  E, Wood C.// International Journal of Gynecology &amp; Obstetrics. 2018 Mar;140(3):370-374. DOI: 10.1002/ijgo.12366</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Management of placenta accreta, diagnosed before birth./A.Dimitrov, T. Garnizov, B. Frundeva et al. // Akush Ginekol (Sofiia). 2015;54(8):13-21.</mixed-citation><mixed-citation xml:lang="en">Management   of   placenta   accreta,   diagnosed before birth./A.Dimitrov, T. Garnizov, B. Frundeva et al. // Akush Ginekol (Sofiia). 2015;54(8):13-21.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Alternative approaches to surgical hemostasis in patients with morbidly adherent placenta undergoing fertility-sparing surgery./ R.G. Shmakov, A.A. Vinitskiy, V.D. Chuprinin, et al.// Journal Matern Fetal Neonatal Med. 2018 Feb 5:1-7. DOI:10.1080/14767058.2018.1424821</mixed-citation><mixed-citation xml:lang="en">Alternative  approaches  to  surgical  hemostasis  in patients with morbidly adherent placenta undergoing fertility-sparing  surgery./  R.G.  Shmakov,  A.A.  Vinitskiy, V.D. Chuprinin, et al.// Journal Matern Fetal Neonatal Med. 2018 Feb 5:1-7. DOI:10.1080/14767058.2018.1424821</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Perioperative and transfusion outcomes in women undergoing cesarean hysterectomy for abnormal placentation / K.F. Brookfield, L.T. Goodnough, D.J. Lyell et al// Transfusion. 2014 Jun; 54(6): 1530-1536. DOI: 10.1111/trf.12483</mixed-citation><mixed-citation xml:lang="en">Perioperative    and   transfusion    outcomes    in women undergoing cesarean hysterectomy for abnormal placentation  /  K.F.  Brookfield,  L.T.  Goodnough,  D.J. Lyell  et al// Transfusion.  2014  Jun;  54(6):  1530-1536. DOI: 10.1111/trf.12483</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">The effects of sevoflurane on isolated gravid human myometrium. / R.J. Turner, M. Lambrost, C. Holmes et al // Anaesth Intensive Care. 2002;30:591-6. DOI: 10.1177/0310057X0203000508</mixed-citation><mixed-citation xml:lang="en">The  effects  of  sevoflurane  on  isolated  gravid human myometrium. / R.J. Turner, M. Lambrost, C. Holmes et al // Anaesth Intensive Care. 2002;30:591-6. DOI: 10.1177/0310057X0203000508</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Afolabi BB. Regional versus general anaesthesia for caesarean section. / B.B. Afolabi, F.E. Lesi // Cochrane Database Syst Rev. 2006;(10):CD004350. DOI: 10.1002/14651858.CD004350.pub3.</mixed-citation><mixed-citation xml:lang="en">Afolabi BB. Regional versus general anaesthesia for  caesarean   section.   /  B.B.  Afolabi,   F.E.   Lesi   // Cochrane   Database   Syst   Rev.   2006;(10):CD004350. DOI: 10.1002/14651858.CD004350.pub3.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">The contribution of anaesthesia modus on reducing blood loss during caesarean section./V. Liberis, P. Tsikouras ,T. Vogiatzaki et al. // Clin Exp Obstet Gynecol. 2009;36: 105-109.</mixed-citation><mixed-citation xml:lang="en">The   contribution   of   anaesthesia   modus   on reducing blood loss during caesarean section./V. Liberis, P. Tsikouras ,T. Vogiatzaki et al. // Clin Exp Obstet Gynecol. 2009;36: 105-109.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Riveros-Perez E. Obstetrics Retrospective analysis of obstetric and anesthetic management of patients with placenta accreta spectrum disorders/ E. Riveros-Perez E, C. Wood // Int J Gynaecol Obstet. 2018 Mar;140(3):370-374. DOI: 10.1002/ijgo.12366</mixed-citation><mixed-citation xml:lang="en">Riveros-Perez E. Obstetrics Retrospective analysis of obstetric and anesthetic management of patients with placenta accreta spectrum disorders/ E. Riveros-Perez E, C. Wood // Int J Gynaecol Obstet. 2018 Mar;140(3):370-374. DOI: 10.1002/ijgo.12366</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Mode of anesthesia and clinical outcomes of patients undergoing Cesarean delivery for invasive placentation: A retrospective cohort study of 50 consecutive cases./ N. Nguyen-Lu, J.C. Carvalho, J. Kingdom et al. //Can J Anaesth. 2016;63:1233-1244. DOI: 10.1007/s12630-016-0695-x.</mixed-citation><mixed-citation xml:lang="en">Mode  of  anesthesia  and  clinical  outcomes  of patients undergoing Cesarean delivery for invasive placentation: A retrospective cohort study of 50 consecutive cases./ N. Nguyen-Lu, J.C. Carvalho, J. Kingdom  et  al.  //Can  J  Anaesth.  2016;63:1233-1244. DOI: 10.1007/s12630-016-0695-x.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Comparison of general and epidural anesthesia in elective cesarean section for placenta previa totalis: Maternal hemodynamics, blood loss and neonatal outcome. / J.Y. Hong, Y.S. Jee, H.J. Yoon et al.// Int J Obstet Anesth. 2003;12:12-16. DOI:10.1016/s0959-289x(02)00183-8</mixed-citation><mixed-citation xml:lang="en">Comparison  of  general  and  epidural  anesthesia in elective  cesarean  section  for placenta  previa  totalis: Maternal hemodynamics,  blood loss and neonatal outcome. / J.Y. Hong, Y.S. Jee, H.J. Yoon et al.// Int J Obstet   Anesth.    2003;12:12-16.    DOI:10.1016/s0959-289x(02)00183-8</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">FIGO consensus guidelines on placenta accreta spectrum disorders: Nonconservative surgical management/ L. Allen, E. Jauniaux, S. Hobson et al. // International Journal of Gynecology&amp;Obstetrics. 2018;140(3):281-290. DOI: 10.1002/ijgo.12409</mixed-citation><mixed-citation xml:lang="en">FIGO     consensus     guidelines     on     placenta accreta   spectrum  disorders:  Nonconservative   surgical management/  L. Allen,  E.  Jauniaux,  S.  Hobson  et  al. //   International    Journal   of   Gynecology&amp;Obstetrics. 2018;140(3):281-290. DOI: 10.1002/ijgo.12409</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Toledano R.D. Anesthetic and Obstetric Management of Placenta Accreta: Clinical Experience and Available Evidence/R.D. Toledano, L. R. Leffert et al. // Current Anesthesiology Reports. 2017;7(1):93-102.</mixed-citation><mixed-citation xml:lang="en">Toledano R.D. Anesthetic and Obstetric Management  of  Placenta  Accreta:  Clinical  Experience and Available  Evidence/R.D. Toledano, L. R. Leffert et al. // Current Anesthesiology Reports. 2017;7(1):93-102.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology First update 2016/ S.A. Kozek-Langenecker, A.B. Ahmed, A. Afshari et al// European Journal of Anaesthesiology. 2017;34:332-395. DOI: 10.1097/EJA.0000000000000630.</mixed-citation><mixed-citation xml:lang="en">Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology First update 2016/ S.A. Kozek-Langenecker, A.B. Ahmed, A. Afshari et al// European Journal of Anaesthesiology. 2017;34:332-395. DOI: 10.1097/EJA.0000000000000630.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Perioperative and transfusion outcomes in women undergoing cesarean hysterectomy for abnormal placentation/K. F. Brookfield, L.T. Goodnough, D. J. Lyell et al//Transfusion. 2014 Jun; 54(6): 1530–1536. DOI: 10.1111/trf.12483</mixed-citation><mixed-citation xml:lang="en">Perioperative    and   transfusion    outcomes    in women undergoing cesarean hysterectomy for abnormal placentation/K.   F.  Brookfield,  L.T.  Goodnough,  D.  J. Lyell  et  al//Transfusion.  2014  Jun;  54(6):  1530–1536. DOI: 10.1111/trf.12483</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Clinical Management Guidelines for Obstetrician– Gynecologists. Postpartum Hemorrhage/Practice bullet// American College of Obstetricians and Gynecologists (ACOG). 2017;183:168-178.</mixed-citation><mixed-citation xml:lang="en">Clinical Management Guidelines for Obstetrician– Gynecologists.  Postpartum Hemorrhage/Practice  bullet// American College of Obstetricians and Gynecologists (ACOG). 2017;183:168-178.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Jiburt Е.В. «Novie» gemotransmissivnie infekcii i ih profilaktika/ E.B. Jiburt // Vestnik «MEDSI». 2012;16:33-39.</mixed-citation><mixed-citation xml:lang="en">Jiburt Е.В. «Novie» gemotransmissivnie  infekcii i   ih   profilaktika/   E.B.   Jiburt   //  Vestnik   «MEDSI». 2012;16:33-39.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry/L.E. Phillips, C. McLintock, W. Pollock et al. // Anesth Analg. 2009 Dec;109(6):1908-15. DOI: 10.1213/ANE.0b013e3181c039e6.</mixed-citation><mixed-citation xml:lang="en">Recombinant activated factor VII in obstetric hemorrhage:  experiences  from the Australian  and New Zealand Haemostasis Registry/L.E. Phillips, C. McLintock, W. Pollock et al. // Anesth Analg. 2009 Dec;109(6):1908-15. DOI: 10.1213/ANE.0b013e3181c039e6.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Experience with recombinant activated factor VII for severe post-partum hemorrhage in Japan, investigated by Perinatology Committee, Japan Society of Obstetrics and Gynecology./M. Murakami ,T. Kobayashi , T. Kubo et al.// J Obstet Gynaecol Res 2015 Aug;41(8):1161-8. DOI: 10.1111/jog.12712</mixed-citation><mixed-citation xml:lang="en">Experience with recombinant activated factor VII for severe post-partum hemorrhage in Japan, investigated by Perinatology Committee, Japan Society of Obstetrics and Gynecology./M. Murakami ,T. Kobayashi , T. Kubo et al.// J Obstet Gynaecol  Res 2015 Aug;41(8):1161-8. DOI: 10.1111/jog.12712</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Recombinant activated factor VII (rFVIIa/ NovoSeven®) in the management of severe postpartum haemorrhage: initial report of a multicentre case series in Japan./ T.Kobayashi, M. Nakabayashi , A. Yoshioka et al.// Int J Hematol. 2012 Jan;95(1):57-63. DOI: 10.1007/s12185-011-0974-9.</mixed-citation><mixed-citation xml:lang="en">Recombinant activated factor VII (rFVIIa/ NovoSeven®) in the management of severe postpartum haemorrhage:  initial report of a multicentre  case series in Japan./ T.Kobayashi, M. Nakabayashi , A. Yoshioka et al.// Int J Hematol. 2012 Jan;95(1):57-63. DOI: 10.1007/s12185-011-0974-9.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trial. /A.J. Wikkelsø, H.M. Edwards, A. Afshari et al. // Br J Anaesth.- 2015 Apr;114(4):623-33. DOI: 10.1093/bja/aeu444.</mixed-citation><mixed-citation xml:lang="en">Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trial. /A.J. Wikkelsø, H.M. Edwards, A. Afshari et al. // Br J Anaesth.- 2015 Apr;114(4):623-33. DOI: 10.1093/bja/aeu444.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage-an observational study./S. Ahmed , C. Harrity , S. Johnson et al//Transfus Med. 2012 Oct;22(5):344-9. DOI: 10.1111/j.1365-3148.2012.01178.x.</mixed-citation><mixed-citation xml:lang="en">The efficacy of fibrinogen concentrate  compared with cryoprecipitate  in major obstetric  haemorrhage-an observational study./S. Ahmed , C. Harrity , S. Johnson et   al//Transfus    Med.   2012   Oct;22(5):344-9.    DOI: 10.1111/j.1365-3148.2012.01178.x.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Physiological changes in pregnancy. /P. Soma-Pillay, C. Nelson-Piercy, H. Tolppanen et al. // Cardiovascular Journal of Africa. 2016;27(2):89-94. DOI:10.5830/cvja-2016-021</mixed-citation><mixed-citation xml:lang="en">Physiological changes in pregnancy. /P. Soma-Pillay, C. Nelson-Piercy, H. Tolppanen et al. // Cardiovascular Journal of Africa. 2016;27(2):89-94. DOI:10.5830/cvja-2016-021</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Coagulation factors in whole blood collected from pregnant women and stored at 4°C/ M. Minatoguchi, A. Itakura, A. Miki et al.// Nagoya J Med Sci. 2016 Feb; 78(1): 1-7.</mixed-citation><mixed-citation xml:lang="en">Coagulation factors in whole blood collected from pregnant women and stored at 4°C/ M. Minatoguchi, A. Itakura, A. Miki et al.// Nagoya J Med Sci. 2016 Feb; 78(1): 1-7.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Safety and efficacy of preoperative autologous blood donation for high-risk pregnant women: experience of a large university hospital in Japan./ Y. Yamamoto , T. Yamashita , N.H. Tsuno et al// J Obstet Gynaecol Res. 2014 May;40(5):1308-16. DOI: 10.1111/jog.12348.</mixed-citation><mixed-citation xml:lang="en">Safety and efficacy of preoperative autologous blood donation for high-risk pregnant women: experience of a large university hospital in Japan./ Y. Yamamoto , T. Yamashita  , N.H. Tsuno et al// J Obstet Gynaecol Res. 2014 May;40(5):1308-16. DOI: 10.1111/jog.12348.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Krovesberegayuschie tehnologii v akusherskoi praktike: klinicheskie rek-omendacii/ G.T. Suhih, V.N. Serov, L.V. Adamyan// Klinicheskie rek-omendacii utv. Rossiiskim obschestvom akusherov_ginekologov. 2014; 15-21.</mixed-citation><mixed-citation xml:lang="en">Krovesberegayuschie tehnologii v akusherskoi praktike: klinicheskie rek-omendacii/ G.T. Suhih, V.N. Serov, L.V. Adamyan//  Klinicheskie  rek-omendacii  utv. Rossiiskim  obschestvom  akusherov_ginekologov.  2014; 15-21.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Walunj Ajit. Autologous blood transfusion./ A. Walunj, A. Babb , R. Sharpe// Continuing Education in Anaesthesia Critical Care &amp; Pain.- 2006; Volume 6, Issue 5, Pages 192-196. DOI:10.1093/bjaceaccp/mkl042</mixed-citation><mixed-citation xml:lang="en">Walunj Ajit. Autologous blood transfusion./ A. Walunj, A. Babb , R. Sharpe// Continuing Education in Anaesthesia Critical Care &amp; Pain.- 2006; Volume 6, Issue 5, Pages 192-196. DOI:10.1093/bjaceaccp/mkl042</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Prevention and Management of Postpartum Haemorrhage. / Royal College of Obstetricians &amp; Gynaecologists.// Guideline № 52. Desember 2016</mixed-citation><mixed-citation xml:lang="en">Prevention and Management of Postpartum Haemorrhage. / Royal College of Obstetricians &amp; Gynaecologists.// Guideline № 52. Desember 2016</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Jadon A. Blood transfusion practices in obstetric anaesthesia./A. Jadon, R. Bagai. // Indian Jounal Anaesth. 2014;58(5):629-636. DOI: 10.4103/0019-5049.144674</mixed-citation><mixed-citation xml:lang="en">Jadon A. Blood transfusion practices in obstetric anaesthesia./A. Jadon, R. Bagai. // Indian Jounal Anaesth. 2014;58(5):629-636. DOI: 10.4103/0019-5049.144674</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">The development and implementation of an obstetric cell salvage service./ N.J. McDonnell, D. Kennedy, L.J. Long et al.// Anaesth Intensive Care. 2010;38:492-499. DOI: 10.1177/0310057X1003800313</mixed-citation><mixed-citation xml:lang="en">The   development   and   implementation   of  an obstetric cell salvage service./ N.J. McDonnell, D. Kennedy,  L.J.  Long  et  al.//  Anaesth  Intensive  Care. 2010;38:492-499. DOI: 10.1177/0310057X1003800313</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Elagamy A. The use of cell salvage in women undergoing cesarean hysterectomy for abnormal placentation. / A. Elagamy, A. Abdelaziz ,M. Ellaithy// Int J Obstet Anesth. 2013;22:289-293. DOI: 10.1016/j.ijoa.2013.05.007</mixed-citation><mixed-citation xml:lang="en">Elagamy  A. The use of cell  salvage  in women undergoing cesarean hysterectomy for abnormal placentation.  / A. Elagamy, A. Abdelaziz  ,M. Ellaithy// Int J Obstet Anesth.  2013;22:289-293.  DOI: 10.1016/j.ijoa.2013.05.007</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Lew E. Implementation of an obstetric cell salvage service in a tertiary women’s hospital./ E. Lew, S. Tagore // Singapore Med J. 2015;56:445-449. DOI: 10.11622/smedj.2015121</mixed-citation><mixed-citation xml:lang="en">Lew E. Implementation of an obstetric cell salvage service in a tertiary women’s hospital./ E. Lew, S. Tagore // Singapore  Med J. 2015;56:445-449.  DOI: 10.11622/smedj.2015121</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Cell salvage and donor blood transfusion during cesarean section: A pragmatic, multicentre randomised controlled trial (SALVO) / K.S. Khan, Moore PAS, M.J. Wilson et al//PLoS Med. 2017;14(12) DOI:10.1371/journal.pmed.1002471</mixed-citation><mixed-citation xml:lang="en">Cell salvage and donor blood transfusion during cesarean  section:  A pragmatic,  multicentre  randomised controlled trial (SALVO) / K.S. Khan, Moore PAS, M.J. Wilson et al//PLoS Med. 2017;14(12) DOI:10.1371/journal.pmed.1002471</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): An international, randomised, double-blind, placebo-controlled trial./ H. Shakur, I. Roberts ,B. Fawole et al. // Lancet. 2017;389:2105-2116. DOI: 10.1016/S0140-6736(17)30638-4</mixed-citation><mixed-citation xml:lang="en">Effect  of  early  tranexamic  acid  administration on  mortality,   hysterectomy,  and  other  morbidities  in women   with   post-partum   haemorrhage   (WOMAN): An international, randomised, double-blind, placebo-controlled trial./ H. Shakur, I. Roberts ,B.  Fawole et al. //  Lancet.  2017;389:2105-2116.   DOI:  10.1016/S0140-6736(17)30638-4</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Tranexamic acid for preventing postpartum blood loss after cesarean delivery: A systematic review and meta-analysis of randomized controlled trials. / G. Simonazzi, M. Bisulli , G. Saccone et al.// Acta Obstet Gynecol Scand. 2016;95:28-37. DOI: 10.1111/aogs.12798</mixed-citation><mixed-citation xml:lang="en">Tranexamic   acid   for   preventing   postpartum blood loss after cesarean delivery: A systematic review and  meta-analysis  of  randomized  controlled  trials.  / G.  Simonazzi,  M.  Bisulli  ,  G.  Saccone  et  al.//  Acta Obstet Gynecol Scand. 2016;95:28-37. DOI: 10.1111/aogs.12798</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Lakshmi S.D. Role of prophylactic tranexamic acid in reducing blood loss during elective caesarean section: A randomized controlled study. / S.D. Lakshmi, R.J. Abraham // Clin Diagn Res. 2016;10:17-21. DOI: 10.7860/JCDR/2016/21702.9050</mixed-citation><mixed-citation xml:lang="en">Lakshmi  S.D.  Role  of  prophylactic  tranexamic acid in reducing blood loss during elective caesarean section: A randomized controlled study. / S.D. Lakshmi, R.J. Abraham  // Clin  Diagn  Res. 2016;10:17-21.  DOI: 10.7860/JCDR/2016/21702.9050</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Role of Intravenous tranexamic acid on caesarean blood loss:A prospective randomised study./ I. Ray, R. Bhattacharya ,S. Chakraborty et al. // J Obstet Gynaecol India. 2017;66:347-352. DOI: 10.1007/s13224-016-0915-x.</mixed-citation><mixed-citation xml:lang="en">Role of Intravenous tranexamic acid on caesarean blood loss:A prospective  randomised  study./ I. Ray, R. Bhattacharya ,S. Chakraborty et al. // J Obstet Gynaecol India.    2017;66:347-352. DOI: 10.1007/s13224-016-0915-x.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">A randomized placebo-controlled trial of preoperative tranexamic acid among women undergoing elective cesarean delivery. / A.M. Maged, O.M. Helal, M.M. Elsherbin et al. // Int J Gynecol Obstet. 2015;131:265-268. DOI: 10.1016/j.ijgo.2015.05.027</mixed-citation><mixed-citation xml:lang="en">A randomized placebo-controlled trial of preoperative tranexamic acid among women undergoing elective    cesarean    delivery.    /   A.M.   Maged,   O.M. Helal,  M.M.  Elsherbin  et  al.  //  Int  J  Gynecol  Obstet. 2015;131:265-268. DOI: 10.1016/j.ijgo.2015.05.027</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
